Your browser doesn't support javascript.
loading
In vitro -In vivo- In silico Simulation of Experimental Design Based Optimized Curcumin Loaded Multiparticulates System.
Singh, Sima; Hussain, Afzal; Lal, Uma Ranjan; Sayyad, Nisar; Karpoormath, Rajshekhar; Nlooto, Manimbulu.
Afiliação
  • Singh S; Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi-835215, Jharkhand, India.
  • Hussain A; Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.
  • Lal UR; Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi-835215, Jharkhand, India.
  • Sayyad N; Faculty of Pharmacy, S. Sinha College, Aurangabad-824101, Bihar, India.
  • Karpoormath R; Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi-835215, Jharkhand, India.
  • Nlooto M; School of Pharmaceutical Sciences, Shoolini University, Solan, Himacahal Pradesh-173229, India.
Curr Pharm Des ; 24(30): 3576-3586, 2018.
Article em En | MEDLINE | ID: mdl-30345913
ABSTRACT
The present study focused to optimize dual coated multiparticulates using Box-Behnken Experimental Design and in-silico simulation using GastroPlusTM software. The optimized formulations (OB1 and OB2) were comparatively evaluated for particle size, morphological, in vitro drug release, and in vivo permeation studies. In silico simulation study predicted the in vivo performance of the optimized formulation based on in-vitro data. Results suggested that optimized formulation was obtained using maximum content of Eudragit FS30D and minimum drying time (2 min). In vitro data corroborated that curcumin release was completely protected from premature drug release in the proximal part of gastro intestinal tract and successfully released to the colon (95%) which was closely predicted (90.1 %) by GastroPlusTM simulation technique. Finally, confocal laser scanning microscopy confirmed the in-vitro findings wherein maximum intensity was observed with OB1 treated group suggesting successful delivery of OB1 to the colon for enhanced absorption as predicted in regional absorption profile in ascending colon (30.9%) and caecum (23.2%). Limited drug absorption was predicted in small intestine (1.5-8.7%). The successful outcomes of the research work minimized the release of curcumin in the upper gastric tract and the maximized drug access to the colon (pH 7.4) as prime concern.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Simulação por Computador / Desenho de Fármacos / Colo / Curcumina / Intestino Delgado Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Curr Pharm Des Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Simulação por Computador / Desenho de Fármacos / Colo / Curcumina / Intestino Delgado Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Curr Pharm Des Ano de publicação: 2018 Tipo de documento: Article